OBJECTIVE: 1) Learn about safety and effectiveness of elective minimally invasive video-assisted (MIVA) central neck dissection (CND) for thyroid carcinoma. 2) Understand benefits and limitations of this procedure. METHOD: Retrospective study of patients undergoing elective MIVA CND at the time of thyroidectomy during November 2006 to October 2009 was performed. Operations were performed by a single surgeon in an academic center. Primary outcomes included complications and recurrence rates. RESULTS: Twenty-eight patients were studied, 16 underwent unilateral, and the remainder bilateral CND. Twenty-five had PTC, one FTC, one MTC, and one Hashimoto's thyroiditis. Fifteen underwent radioiodine ablation. There were no recurrences with mean follow-up of ten months (range 4-35). Eleven patients (42%) had positive central lymph nodes for metastases. No permanent hypocalcemia resulted, though three (10.7%) patients experienced transient hypocalcemia on POD1 (Ca less than eight). No permanent hypoparathyroidism resulted, though seven (25%) patients had transient hypoparathyroidism (PACU PTH less than eight) treated with shortterm supplementation. No permanent vocal cord paralysis occurred, however transient recurrent laryngeal nerve paresis requiring no intervention occurred in one (3.6%) patient. Excluding patients with positive thyroglobulin antibodies, five had elevated thyroglobulin at one month, and each of these values decreased six months later. At most recent check, 86% of patients had low/undetectable (less than one) thyroglobulin. CONCLUSION: Elective central neck dissection performed with thyroidectomy via a MIVA approach is a safe and effective procedure in our institutional experience. Prospective studies comparing the open and video-assisted approaches need to be performed to make definitive recommendations.
Minimally Invasive Video-Assisted Thyroid Surgery Pain Trial
James O'Neill, MB, MRCSI, MMSc, MD, MBA (presenter)
OBJECTIVE:
The analysis of this prospective study was to compare pain score results in patients who underwent minimally invasive video-assisted (MIVAT) versus minimally invasive open thyroidectomy (MIT) and in doing so further extrapolate and understand the potential advantages of videoassisted thyroid surgery. METHOD: A total of 98 patients post-minimally invasive thyroidectomy from January 1 to December 31, 2008, are the subject matter of this study. Pain scores (0-10) assigned by the patients shortly after the thyroidectomy and after 24 hours post-operative forms the basic outcome variable. For statistical comparison of the distribution of the pain scores between patients the Kolmogrov-Smirnov test was employed. RESULTS: The comparison pain score distribution using Kolmogorov-Smirnov test for post-operative assessment yielded a Z-value of 2.84 (P Ͻ 0.001). The comparison pain score distribution at 24hrs yielded a Z-value of 1.48 (P Ͻ 0.05). These results imply the difference in distribution of pain scores among MIT and MIVAT group to be statistically significant. CONCLUSION: Video-assisted thyroidectomy appears to reduce the pain in patients shortly after the operation and 24 hours post-operative. The reduction is statistically significant. Male patients appear to report less pain compared to their female counterparts.
Molecular Imaging-Assisted Surgery for Head and Neck Cancer
Shunsuke Miyamoto, MD (presenter); Taku Yamashita, MD, PhD; Bert O'Malley, MD; Daqing Li, MD OBJECTIVE: 1) Apply molecular imaging technique to head and neck oncology surgery. 2) Detect on-site residual or microscopic tumors during resection. 3) Determine whether molecular imaging-assisted surgery may improve treatment outcomes for head and neck cancer.
METHOD:
We have developed the first orthotopic mouse model of head and neck squamous cell carcinoma (HNSCC) expressing the green florescence protein (GFP) gene detected by a dynamic molecular imaging system. This mouse model was used for the current study. Tumors were detected by the Kodak Molecular Imaging System before surgery and confirmed histologically. Mice were divided into different groups, with or without molecular imaging-assisted surgery. After original total tumor resection with no visible tumor, the molecular imaging system was used on-site for detecting residual or microscopic tumors. The mice with residual or microscopic tumor underwent a further tumor resection. Cisplatin-based chemotherapy was used postoperatively for combined therapy groups. RESULTS: The molecular imaging system demonstrated the advantages of detecting and tracking residual or microscopic tumors that cannot be found by unaided eye after a total tumor resection. The mice treated with molecular imaging-assisted surgery had significantly prolonged survival after tumor resection. With combined surgery and chemotherapy, the mice treated with molecular imaging-assisted surgery greatly improved the treatment outcomes. CONCLUSION: The molecular imaging system is a noninvasive diagnostic tool for detecting and tracking residual tumor and tumor growth. The molecular imaging-assisted surgery may significantly improve treatment outcomes in the surgical resection of HNSCC and further development and research is warranted.
Nasopharyngeal Endoscopic Resection: Surgical Perspectives
Paolo Battaglia, MD (presenter); Andrea Bolzoni Villaret, MD; Maurizio Bignami, MD; Piero Nicolai, MD; Paolo Castelnuovo, MD OBJECTIVE: 1) Describe different surgical endoscopic approaches to the nasopharynx according to the local extension of the disease. 2) Evaluate the efficacy of endoscopic surgery in the management of selected nasopharyngeal tumors (NPTs). METHOD: From 1997 to 2010, 23 patients (13 male, 10 female, mean age 48 years) with previously untreated (8) or recurrent NPTs (15) were treated with curative intent by pure endoscopic resection. The extent of surgical resection was classified in: type 1 NER (Nasopharyngeal Endoscopic Resection): resection limited to the postero-superior nasopharyngeal wall reaching the bony floor of the sphenoid sinus; type 2 NER: resection extended superiorly to the sphenoid sinus; type 3 NER: resection with lateral extension including the cartilaginous portion of the Eustachian tube and parapharyngeal space. RESULTS: Type 1 NER was performed in 4 cases, type 2 in 10, and type 3 in 9. No intra-or postoperative complications were observed. Mean hospitalization stay was 4.2 days. The lesions were staged according to the UICC TNM staging system classification: stage I, 12 (52.2%); stage II, 2 (8.7%); stage III, 6 (26.1%) and stage IV, 3 (13%). Mean follow-up was 37 months. Five years disease-specific survival was 76.8 12.3. CONCLUSION: NER is a feasible surgical technique in the treatment of selected previously untreated or recurrent NPTs, which can be modulated in relation to tumor extension. This approach may be considered a suitable option in the treatment of selected NPTs. Larger series of patients and a longer follow-up are needed to better define the role of NER.
Nasopharyngectomy for Recurrent NPC: A Multivariate Analysis
Alexander Vlantis, FCS(SA)ORL (presenter); Hing-Sang Chan; Brian K H Yu, MD; Michael C F Tong; C Andrew van Hasselt, FRCSE OBJECTIVE: To identify prognostic factors for (i) local relapse-free survival and (ii) overall survival in patients who undergo surgical salvage nasopharyngectomy for residual or recurrent nasopharyngeal carcinoma. METHOD: A retrospective case series review was conducted of 97 patients with operable residual or recurrent nasopharyngeal carcinoma who underwent a surgical salvage nasopharyngectomy at an academic tertiary referral center between November 1987 and June 2007. Survival was estimated using the Kaplan-Meier product-limit method and potential clinical prognostic factors tested individually for their effect on local relapse-free survival and overall survival at 5 years using Cox's proportional hazards model. Factors that achieved sig-
